Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense and nuclear medicine.

D J Hnatowich1

  • 1Department of Nuclear Medicine, University of Massachusetts Medical Center, Worcester 01655, USA.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|April 21, 1999
PubMed
Summary

Antisense deoxyribonucleic acids (DNAs) show promise in chemotherapy and may be valuable for nuclear medicine imaging. Further research is needed to optimize their use in imaging applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2010
Same author

[Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2008
Same author

Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery.

Cancer gene therapy·2007
Same author

[Experimental study of 99mTc-antisense DNA for tumor imaging].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2007
Same author

Evidence of antisense tumor targeting in mice.

Bioconjugate chemistry·2004
Same author

Investigations of 99mTc morpholino pretargeting in mice.

Nuclear medicine communications·2003

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nuclear Medicine

Background:

  • Synthetic single-strand antisense deoxyribonucleic acids (DNAs) are in clinical trials for various diseases, including viral infections, cancers, and inflammatory disorders.
  • Early clinical trial results for antisense DNAs in chemotherapy are encouraging, suggesting their future importance.

Purpose of the Study:

  • To explore the potential of antisense DNAs for nuclear medicine imaging.
  • To identify shared and divergent properties between antisense DNA chemotherapy and imaging applications.

Main Methods:

  • Review of existing research on antisense DNA mechanisms, cellular transport, and localization.
  • Comparison of property requirements for antisense DNA in chemotherapy versus nuclear medicine imaging.

Main Results:

  • Many properties beneficial for antisense DNA chemotherapy, like in vivo stability and cell transport, are also suitable for imaging.
  • Key differences exist, particularly the need for rapid radiolabel kinetics and prolonged target retention in imaging.

Conclusions:

  • Antisense DNAs hold potential for nuclear medicine imaging, leveraging advancements from the chemotherapy field.
  • Significant optimization efforts are required to adapt antisense DNAs for effective imaging and radiotherapy applications.
  • The ability to target specific tissues makes antisense DNA imaging a worthwhile area for development.

Related Experiment Videos